Platelet-rich Plasma Versus Corticosteroid Injection for the Treatment of Femoroacetabular Impingement

• Status: Terminated
• Trial end date: 2018-08-10
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the clinical response of intra-articular platelet rich plasma (PRP) versus corticosteroid injection in patients affected by femoroacetabular impingement (FAI).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Michigan
• Treatments: Triamcinolone Acetonide

Criteria

Inclusion Criteria:

• Patients with symptomatic FAI

• Clinical and radiographic evidence of FAI

• Patients able to provide consent to study participation

• Completion of 6 weeks of physical therapy program

Exclusion Criteria:

• Established Osteoarthritis (Kellgren-Lawrence > 3)

• Minimum joint space > 2 mm as measured on AP radiograph

• Hip dysplasia (center edge angle < 20° on AP radiograph)

• Patients with clinically significant cardiovascular, renal, hepatic, endocrine disease, cancer or diabetes

• Patients with ongoing infection including HIV and Hepatitis

• Patient with history of osteomyelitis/septic arthritis

• Anticoagulation therapy

• Patients who are pregnant or breast feeding

• Patients with systemic, rheumatic or inflammatory disease of the knee or chondrocalcinosis, hemochromatosis, inflammatory arthritis, arthropathy of the knee associated with juxta-articular Paget's disease of the femur or tibia, hemophilic arthropathy, infectious arthritis, Charcot's knee joint, villonodular synovitis, and synovial chondromatosis

• Patients taking immunosuppressant medication

• Patients with abnormal hematology or serum chemistry lab results

• Patients receiving injection to treatment knee within 2 months of study enrollment

• BMI greater than 35 or less than 20